New Technology May More Accurately Assess Bone Health

August 29, 2022 – Last week, Athens, OH-based OsteoDx installed their CBMT™ devices in research facilities at the University of South Florida’s Morasani College of Medicine and the University of Florida College of Medicine to begin patient research studies.

OsteoDx has two other research studies in partnership with Indiana University’s School of Medicine in Indianapolis and at the Ohio Musculoskeletal and Neurological Institute at Ohio University’s Heritage College of Osteopathic Medicine. The company’s The STRONGER Study is using its proprietary Cortical Bone Mechanics Technology™ (CBMT) to enhance the understanding of bone health.

“This is a big step for OsteoDx in our journey to commercialization of the CBMT technology,” said Ron Lachey, acting CEO and Executive in Residence for TechGrowth Ohio. “This technology has the potential to truly be a game-changer for predicting risk of bone fracture.”

OsteoDx has the exclusive license for the commercialization of the Cortical Bone Mechanics Technology, developed by world-renowned experts in bone mechanics at Ohio University in Athens, Ohio.  The technology very accurately measures bone stiffness of the ulna (a forearm bone), which is near perfectly correlated with bone strength. CBMT is embodied in OsteoDx’s new device and proprietary data analysis software that non-invasively, painlessly, and quickly measures the stiffness of an individual’s ulna. CBMT may provide a more accurate diagnostic of osteoporosis because it is the only device that directly measures the biomechanical properties of bone, and especially bone stiffness and strength.

The STRONGER Study is currently working with voluntary participants who are post-menopausal women between the ages of 50-80. One-third of these participants have already experienced an arm or leg fracture after the age of 50. There is significant existing data that suggests that more accurately assessing bone health may allow for earlier and improved interventions to prevent future fractures through highly targeted administration of available treatment options. The STRONGER Study seeks to establish the discriminatory accuracy of the CBMT device.

OsteoDx, Inc., was originally founded in September of 2016 as AEIOU Scientific, an Ohio-based LLC. Working with TechGrowth Ohio, the company converted to OsteoDx, Inc., a Delaware C-Corporation, in 2020. The leadership team is comprised of acknowledged experts in bone health/fracture research, mechanical engineering, vibration analysis, and commercial startup experience with successful corporate exits. OsteoDx has also been selected and featured as one of 20 start-ups nationwide by the Association of Public and Land-grant Universities and the Association of American Universities for the 2019 University Innovation & Entrepreneurship Showcase in Washington, D.C. Moreover, in 2020, they were selected as the “Most Innovative Technology” by NASA iTech Ohio and were a finalist for this award at the national level. You can learn more about OsteoDx at

TechGrowth Ohio is a $75 million public-private partnership based at Ohio University (OHIO). As one of the premier programs of the Ohio University Voinovich School of Leadership and Public Service, TechGrowth Ohio has a strong track record of partnering with creative entrepreneurs as they make their dreams a reality.  You can learn more about our work at